Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine. Cancer Lett. 2011 Aug 01; 307(1):53-61.
View in:
PubMed
subject areas
Annexin A5
Annexin A5
Antimetabolites
Antimetabolites
Aorta
Aorta
Breast Neoplasms
Breast Neoplasms
Cell Survival
Cell Survival
Cells, Cultured
Cells, Cultured
Combined Modality Therapy
Combined Modality Therapy
Cytosine Deaminase
Cytosine Deaminase
Endothelium, Vascular
Endothelium, Vascular
Female
Female
Flucytosine
Flucytosine
Fluorouracil
Fluorouracil
Genetic Therapy
Genetic Therapy
Humans
Humans
Phosphatidylserines
Phosphatidylserines
Prodrugs
Prodrugs
Recombinant Fusion Proteins
Recombinant Fusion Proteins
authors with profiles
Roger G Harrison